Invezz

Centene Corp (CNC)

NYSE Market Closed

Centene Corporation is a US managed care company built around government-sponsored health insurance programmes. Its core business is administering benefits for Medicaid members on behalf of states, while also serving people through Medicare products, Affordable Care Act marketplace plans, and Medicare Part D prescription drug coverage. This focus gives Centene a central role in healthcare access for lower-income families, people with complex health needs, seniors, and individuals buying subsidised coverage on the exchanges.

The company operates health plans across numerous US states and earns revenue primarily from premiums paid by government agencies and members. Medicaid remains its largest membership category, supported by long-term contracts with state governments that outsource care coordination and claims administration to private insurers. Centene also participates in the individual insurance exchanges, where it offers coverage to consumers who do not receive employer-sponsored insurance, and it maintains a smaller presence in Medicare, including drug plans.

Centene’s model depends on managing medical costs while meeting regulatory requirements and quality standards. It works with provider networks, pharmacies, and care management programmes to coordinate treatment, process claims, and support preventive care. Because its membership is heavily tied to public programmes, the company is sensitive to changes in state and federal healthcare policy, reimbursement rates, eligibility rules, and enrolment trends.

For investors, Centene is distinctive because it is one of the largest pure-play operators in government-backed managed care. Its scale, Medicaid expertise, and exchange footprint give it broad exposure to public healthcare spending, but also leave performance closely linked to regulation, contract renewals, and medical cost trends.

63.41 USD
−0.33 (-0.52%)

Last updated

Market Cap
$31,311,667,770
P/E
P/FCF
4.4
P/S
0.16
Enterprise Value
$26,418,667,770
Sector
Health Care
Industry
Managed Health Care
Address
7700 FORSYTH BLVD., ST LOUIS, MO, 63105
yahoo.com

The Real Risk Inside UnitedHealth Stock

Jul 20, 2026, 10:43 AM
yahoo.com

UnitedHealth Earnings Crush Estimates and Give These Stocks a Boost

Jul 16, 2026, 06:38 AM
nasdaq.com

Broader Market Settles Higher as Positive Inflation News Outweighs Chip Rout

Jul 15, 2026, 18:35 PM
nasdaq.com

Stocks Supported By Favorable Inflation News

Jul 15, 2026, 11:49 AM
yahoo.com

Insurance stocks fall after Elevance Health results show margin pressure

Jul 15, 2026, 07:21 AM
yahoo.com

Centene Corporation (CNC) Rallied Following the Robust Result

Jul 14, 2026, 09:32 AM
yahoo.com

1 Large-Cap Stock with Exciting Potential and 2 We Turn Down

Jul 14, 2026, 04:39 AM
yahoo.com

Centene (CNC) Joins Growth Indexes On A Narrative That May Already Be Priced In

Jul 10, 2026, 19:11 PM
yahoo.com

Warburg Pincus nears $7 billion deal for PANTHERx Rare, WSJ reports

Jul 10, 2026, 13:35 PM
yahoo.com

RBC Initiates Centene (CNC) Coverage and Says the Worst of 2025 Is Firmly in the Rearview Mirror

Jul 01, 2026, 17:35 PM
investing.com

Philip Morris Beats Estimates as Smoke-Free Products Drive Earnings Momentum

Feb 06, 2026, 11:20 AM
globenewswire.com

CENTENE FINAL DEADLINE ALERT: Bragar Eagel & Squire, P.C. Urges Investors in Centene Corporation (CNC) to Inquire About Their Rights in Class Action Lawsuit Before the September 8th Deadline

Sep 07, 2025, 10:38 AM
globenewswire.com

Faruqi & Faruqi Reminds Centene Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of September 8, 2025 - CNC

Sep 07, 2025, 10:31 AM
globenewswire.com

CNC DEADLINE MONDAY: ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages Centene Corporation Investors to Secure Counsel Before Important September 8 Deadline in Securities Class Action – CNC

Sep 06, 2025, 18:24 PM
globenewswire.com

LINE LAWSUIT NOTICE: Lose Money on Lineage, Inc.? Contact BFA Law Prior to September 30 Legal Deadline (NASDAQ:LINE)

Sep 06, 2025, 07:18 AM
globenewswire.com

CNC LAWSUIT NOTICE: Lose Money on Centene Corporation? Contact BFA Law Prior to September 8 Legal Deadline (NYSE:CNC)

Sep 06, 2025, 07:18 AM
globenewswire.com

Centene Corporation Sued for Securities Law Violations - Contact Levi & Korsinsky Before September 8, 2025 to Discuss Your Rights – CNC

Sep 05, 2025, 16:57 PM
globenewswire.com

CENTENE ALERT: Bragar Eagel & Squire, P.C. Urges Investors in Centene Corporation (CNC) to Inquire About Their Rights in Class Action Lawsuit Before the September 8th Deadline

Sep 05, 2025, 10:45 AM
globenewswire.com

CNC INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Centene Corporation Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

Sep 03, 2025, 16:00 PM
globenewswire.com

CNC FINAL DEADLINE: ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Centene Corporation Investors with Losses in Excess of $100K to Secure Counsel Before Important September 8 Deadline in Securities Class Action – CNC

Sep 03, 2025, 00:28 AM
Market Cap
$31,311,667,770
Enterprise Value
$26,418,667,770
P/E
P/B
1.46
P/S
0.16
EV / EBITDA
9.2
EV / Sales
0.13
EPS
-13.05
Dividend Yield
0.06%
P/FCF
4.4
P/CF
3.94
Free Cash Flow
$7,112,000,000
ROE
-30.07%
ROA
-7.94%
Debt / Equity
0.76
Current Ratio
2.37
Quick Ratio
2.37
Cash
1.2
Avg Volume
$4,904,458
Fundamentals Snapshot Price
63.41

Income Statement

Line Item 2026 Q1 2025 Q4 2025 Q3 2025 Q2 2025 Q1
Revenue 50.35B 50.09B 50.14B 49.11B 47B
Cost of revenue 38.3B 41.49B 40.9B 38.81B 36.5B
Gross profit 12.05B 8.61B 9.24B 10.31B 10.5B
Operating income 2.26B -1.38B -6.5B -87M 1.92B
EBITDA 2.57B -534M 556M 283M 2.23B
Net income 1.54B -1.1B -6.63B -253M 1.31B
Income taxes 560M -443M -42M 2M 432M
Interest expense -164M -168M -170M -170M -170M
Other operating expenses 6.39B 6.61B 12.6B 7.36B 5.23B
Total operating expenses 48.09B 51.47B 56.64B 49.2B 45.09B
Basic EPS 3.13 -2.24 -13.5 -0.51 2.64
Diluted EPS 3.11 -2.24 -13.5 -0.51 2.63

Balance Sheet

Line Item 2026 Q1 2025 Q4 2025 Q3 2025 Q2 2025 Q1
Total assets 81.18B 76.75B 82.09B 86.4B 87.04B
Total liabilities 59.65B 56.69B 61.03B 58.89B 59.03B
Total equity 21.53B 20.06B 21.06B 27.5B 28.02B
Cash & equivalents 21.26B 17.89B 17.06B 14.51B 14.82B
Current assets 42.12B 37.41B 41.58B 37.48B 38.66B
Current liabilities 17.79B 14.53B 17.53B 13.52B 13.95B
Accounts payable 16.83B 13.8B 16.88B 13.52B 13.95B
Receivables 19.43B 18.11B 23.11B 21.55B 22.44B
Goodwill 10.84B 10.84B 10.84B 17.56B 17.56B
Long-term debt 16.37B 17.4B 17.58B 17.58B 18.32B

Cash Flow

Line Item 2026 Q1 2025 Q4 2025 Q3 2025 Q2 2025 Q1
Operating cash flow 4.37B 437M 1.36B 1.79B 1.51B
Investing cash flow 89M 660M 1.24B -899M -529M
Financing cash flow -1.06B -187M -10M -1.17B -250M
Change in cash 3.39B 910M 2.59B -288M 731M
Net income 1.54B -1.1B -6.63B -259M 1.31B
Kind Filing Date Link
edgar index 4 — CENTENE CORP View Filing
form 4 Form 4 — Tyler Lauren M View Filing
edgar index 4 — CENTENE CORP View Filing
edgar index 4 — CENTENE CORP View Filing
edgar index 4 — CENTENE CORP View Filing
edgar index 4 — CENTENE CORP View Filing
edgar index 4 — CENTENE CORP View Filing
form 4 Form 4 — COUGHLIN CHRISTOPHER J View Filing
form 4 Form 4 — COUGHLIN CHRISTOPHER J View Filing
form 4 Form 4 — EPPINGER FREDERICK H View Filing
form 4 Form 4 — Samuels Theodore R. II View Filing
form 4 Form 4 — Samuels Theodore R. II View Filing
form 4 Form 4 — TANJI KENNETH View Filing
form 4 Form 4 — Tyler Lauren M View Filing
edgar index 8-K — CENTENE CORP View Filing
edgar index 3 — CENTENE CORP View Filing
eight k text 8-K — 8-K View Filing
form 3 Form 3 — Tyler Lauren M View Filing
edgar index 4 — CENTENE CORP View Filing
form 4 Form 4 — SMITH SUSAN RAYE View Filing
edgar index 4 — CENTENE CORP View Filing
edgar index 144 — CENTENE CORP View Filing
form 4 Form 4 — Burdick Kenneth A View Filing
form 4 Form 4 — Burdick Kenneth A View Filing
edgar index 4 — CENTENE CORP View Filing
form 4 Form 4 — Carson Michael A View Filing
form 4 Form 4 — Carson Michael A View Filing
form 4 Form 4 — Carson Michael A View Filing
edgar index 4 — CENTENE CORP View Filing
form 4 Form 4 — Carson Michael A View Filing
form 4 Form 4 — Carson Michael A View Filing
form 4 Form 4 — Carson Michael A View Filing
edgar index 3 — CENTENE CORP View Filing
edgar index 3 — CENTENE CORP View Filing
form 3 Form 3 — Carson Michael A View Filing
form 3 Form 3 — Carson Michael A View Filing
form 3 Form 3 — Carson Michael A View Filing
form 3 Form 3 — Finke Daniel P View Filing
edgar index 8-K — CENTENE CORP View Filing
eight k text 8-K — 8-K View Filing
edgar index 4 — CENTENE CORP View Filing
edgar index 4 — CENTENE CORP View Filing
edgar index 4 — CENTENE CORP View Filing
edgar index 4 — CENTENE CORP View Filing
edgar index 4 — CENTENE CORP View Filing
edgar index 4 — CENTENE CORP View Filing
edgar index 4 — CENTENE CORP View Filing
edgar index 4 — CENTENE CORP View Filing
form 4 Form 4 — BLUME JESSICA L. View Filing
form 4 Form 4 — BLUME JESSICA L. View Filing
form 4 Form 4 — Burdick Kenneth A View Filing
form 4 Form 4 — Burdick Kenneth A View Filing
form 4 Form 4 — COUGHLIN CHRISTOPHER J View Filing
form 4 Form 4 — COUGHLIN CHRISTOPHER J View Filing
form 4 Form 4 — Dallas H James View Filing
form 4 Form 4 — Dallas H James View Filing
form 4 Form 4 — EPPINGER FREDERICK H View Filing
form 4 Form 4 — FORD MONTE E View Filing
form 4 Form 4 — Samuels Theodore R. II View Filing
form 4 Form 4 — Samuels Theodore R. II View Filing
form 4 Form 4 — TANJI KENNETH View Filing
edgar index SCHEDULE 13G — CENTENE CORP View Filing
edgar index 10-Q — CENTENE CORP View Filing
edgar index 8-K — CENTENE CORP View Filing
eight k text 8-K — 8-K View Filing
edgar index 4 — CENTENE CORP View Filing
form 4 Form 4 — MCNALLY TANYA M View Filing
edgar index 4 — CENTENE CORP View Filing
edgar index 4 — CENTENE CORP View Filing
edgar index 4 — CENTENE CORP View Filing
edgar index 4 — CENTENE CORP View Filing
form 4 Form 4 — COUGHLIN CHRISTOPHER J View Filing
form 4 Form 4 — COUGHLIN CHRISTOPHER J View Filing
form 4 Form 4 — EPPINGER FREDERICK H View Filing
form 4 Form 4 — Samuels Theodore R. II View Filing
  • Trusted by 1M+ investors
  • Global coverage
  • Real-time market data
  • Independent & unbiased

Join thousands making smarter investment decisions.

Get started for free